The Adriano bio forms a high-profile part of a dramatic build in sports content, including non-live programming, over the ...

A friend of Jeffrey Epstein was a VIP guest at the unveiling of a towering golden statue of President Donald Trump at his ...

Kyle Loftis, a YouTuber who gained millions of followers for his underground street-racing page, has died, his company said.

New office in Boston-Cambridge innovation hub to expand partnerships with healthcare and life sciences leaders Supported through a Korea Health Industry Development Institute global expansion program ...

Bite By Night features a VIP membership system that can be purchased using Scraps, the in-game currency, or Robux. Upon unlocking the membership, you can get a myriad of benefits like additional Scrap ...

Want to know what you get when you purchase the VIP game pass in Bite By Night? As you can probably guess from the name, Bite By Night is a Roblox experience that's inspired by Dead by Daylight and ...

IT IS EASY for politicians to forget, amid the trappings of power, that they are public servants. But not for Narendra Modi. India’s prime minister has always insisted that the government exists to ...

Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...

The Massachusetts Gaming Commission is eyeing regulations for VIP programs used by online sports betting companies that offer perks to frequent bettors. VIP or loyalty programs at companies like ...

If you filed a claim in Facebook's $725 million privacy settlement, you could soon get a payment, according to the settlement's administrator. Millions of consumers who used Facebook over a 15-year ...

A year and a half ago, a reader posed a newsletter question to the food editor at Bloomberg Pursuits (me): Do restaurant servers hate diners? To answer that thought-provoking query, I turned to Adam ...

INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...